Navigation Links
Insect research heads down path to start-up company with NSF I-Corps program
Date:2/26/2013

RENO, Nev. A team of researchers at the University of Nevada, Reno have strayed from the lab to the boardroom in an effort to build a business based on discoveries from years of research studying insect enzymes.

The work of Claus Tittiger, professor of biochemistry, and post-doctoral researcher Rubi Figueroa-Teran was accepted into a highly competitive and intense National Science Foundation business-validation program, known as Innovation Corps or I-Corps. Three months later and with the support of the University's Technology Transfer Office programs, they have now created a business and are bringing to market a product based on their enzymes.

Plans are underway to put the technological processes into mass production with the launch of a specialized chemical production company, EscaZyme Biochemicals.

The enzymes, discovered in bark beetles from trees in the Lake Tahoe area, have the potential to be used for a wide range of products such as bug traps and pesticides, perfumes, flavorings, cleaning products or even with drugs for chemotherapy and bacterial infection. After a roller-coaster ride of possibilities and contacting companies in a number of industries, the team settled on the pesticide and insect attractant application as the starting place for the business venture.

The team then expanded, getting a CEO on board, Jennifer Ott, who has a chemistry degree and is completing her MBA at the University this year. Her first order of business was turning EscaZyme Biochemicals into a Nevada limited liability company. She has just met with their first potential client, a chemical company that produces traps and lures for bark beetles, a tiny insect that can decimate a forest in just a few years.

"Our customers are governments, ranchers, timber companies, ski resorts, anyone who is interested in forest health and management," Ott said. "The company we visited is interested because our process produces very easily t
'/>"/>

Contact: Mike Wolterbeek
mwolterbeek@unr.edu
University of Nevada, Reno
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Color in fossil insects, diamonds from the ancient ocean floor and modeling the worlds largest rivers
2. Insects scientists and children meeting in Las Cruces, New Mexico
3. Southern insect scientists to meet in Baton Rouge in March
4. Finding Mr. Right, how insects sniff out the perfect mate
5. Ancient insects shed light on biodiversity
6. USDA grant advancing deadly plant disease, insect research
7. Combating USDAs top-ranked invasive insect
8. Arming US troops with insect-protective gear
9. NSF-funded inventory of mega-diverse insect order now underway
10. Dolphin hearing system component found in insects
11. Insect-eating bat outperforms nectar specialist as pollinator of cactus flowers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Insect research heads down path to start-up company with NSF I-Corps program
(Date:7/31/2015)... The 10 th International Conference on Genomics (ICG-10, ... in Shenzhen , China ... anniversary this year. Since its inauguration in 2006, ICG ... in the ,omics, fields, and is one of the most ... focuses on recent breakthroughs and advances in ,omics, research that ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/27/2015)... JOSE, Calif. , July 27, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... ® touchscreen solution for its stylish smartwatch. ... for its proven reliability, low power and highly ... a wet finger. Huawei designers also required a ...
Breaking Biology News(10 mins):The 10th International Conference on Genomics (ICG-10) to Open in October 2CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... from “vile and cynical exploitation?by the alternative medicines industry, argues ... estimated that up to 80% of all patients with cancer ... help treat their cancer, writes Jonathan Waxman, Professor of Oncology ... the use of many of these approaches is obtuse ?one ...
... chemotherapy with short-term structural changes in cognitive areas ... Published in the January 1, 2007 issue of ... the American Cancer Society, the study reveals that ... regions of the brain associated with memory, analysis ...
... by other patients whose treatment has to be dropped to ... New guidance from the National Institute for health and Clinical ... it provides no extra funding and does not suggest what ... leaves medical staff with difficult decisions to make. , ...
Cached Biology News:Protect patients from exploitation by alternative medicines industry 2Chemotherapy temporarily affects the structures of the human brain 2Other patients bear the real cost of Herceptin 2
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that it ... Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is an ... and how agriculture impacts their daily lives. This unique exhibit also features a birthing ...
(Date:7/30/2015)... 2015 According to a new ... Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract ... Trial), by End Users - Global Forecast to 2020", ... reach USD 2,107.99 million by 2020 from USD 1,034.93 ... Browse more than 75 ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, ... has been granted,U.S. Patent 7,264,798 entitled "Sensitization ... Virus." The claims describe a method of,using ... drug,resistance to chemotherapeutic agents. "Recent research ...
... Hyatt New York on Monday, September 10th, ... a biopharmaceutical company developing patient-specific, active,immunotherapies for the ... Ph.D., President and Chief Executive Officer, will present ... 1:30 p.m. Eastern,time on Monday, September 10, 2007. ...
... in ... Hong Kong, China, SAN ... leading China biometrics company Miaxis,Biometrics Co., Ltd has been officially selected ... The news has been,announced at a gala dinner during the ,Red ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent 2Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 2Miaxis Biometrics Named as 'Red Herring 100 Asia' Award Winner for 2007 3
... Assay with FAM-Labeled Substrate (green fluorescence; ... measure serine protease activation • No ... FLISP Kits utilize cell-permeable, fluorescently labeled ... measure chymotrypsin-like activity in whole living ...
... Engine instrument is the cycler that ... thermal uniformity and swappable blocks ensure ... This rugged machine is more ... platform for new features and upgrades ...
... The Easy Cap tool provides ... seat domed double-locking caps in tubes ... has a wide end that firmly ... prevent accidental crushing when opening or ...
... Multiple Species Tissue Array (MSTA) slides were designed ... and tissues from multiple species. Tissue slices ... MSTA slide which can then be treated as ... or in situ hybridization. This ...
Biology Products: